Follow US:
SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants
UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts
UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed
New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders
Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells
UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines
As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...
UC Riverside mouse study focuses on the receptor TNFR1
UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome
UC Riverside-led mouse study finds a receptor greatly contributes to the harmful effects of plastic-associated chemicals
UC Riverside-led team identifies molecular driver and protector of this life-threatening medical emergency
Lei Stanley Qi of Stanford University will give the 2021 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
UC Riverside-led study in mice and human tissue is the first to show how a disease mutation weakens barrier properties of epithelial cells lining the gut
UC Riverside experts share their thoughts
UC Riverside mouse study suggests inflammation could play key role in progression to asthma
PANDORA sequencing method developed by UC Riverside-led team can detect once-undetectable small RNAs
UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
UC Riverside-led mouse study stresses MS treatment should be started early
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines
